Selected research
Market Structure
Global Nitinol Thrombectomy Stent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Nitinol Thrombectomy Stent market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Nitinol Thrombectomy Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Nitinol Thrombectomy Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Nitinol Thrombectomy Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Nitinol Thrombectomy Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Nitinol Thrombectomy Stent include Acandis GmbH, Balt Group, Furukawa Techno Material, Johnson & Johnson MedTech, Penumbra, Rapid Medical, Stryker, Guichuangtongqiao Medical and Hemu Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Nitinol Thrombectomy Stent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Nitinol Thrombectomy Stent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Nitinol Thrombectomy Stent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nitinol Thrombectomy Stent market size, projected growth trends, production technologies, key applications, and end-use industries.
Nitinol Thrombectomy Stent Segment by Company
Acandis GmbH
Balt Group
Furukawa Techno Material
Johnson & Johnson MedTech
Penumbra
Rapid Medical
Stryker
Guichuangtongqiao Medical
Hemu Biotech
Jianshi Medical
Medtronic
Sinoshenchang Medical
Suzhou Zhongtian Medical
Micro-Port Shentong Medical
Xinkainuo Medical
Xinwei Medical
Nitinol Thrombectomy Stent Segment by Type
Diameter 3MM
Diameter 4MM
Diameter 6MM
Other
Nitinol Thrombectomy Stent Segment by Application
Hospital
Clinic
Other
Nitinol Thrombectomy Stent Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nitinol Thrombectomy Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nitinol Thrombectomy Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nitinol Thrombectomy Stent.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Nitinol Thrombectomy Stent market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nitinol Thrombectomy Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nitinol Thrombectomy Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Nitinol Thrombectomy Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Diameter 3MM
- Diameter 4MM
- Diameter 6MM
- Other
Applications
- Hospital
- Clinic
- Other
Companies covered
- Acandis GmbH
- Balt Group
- Furukawa Techno Material
- Johnson & Johnson MedTech
- Penumbra
- Rapid Medical
- Stryker
- Guichuangtongqiao Medical
- Hemu Biotech
- Jianshi Medical
- Medtronic
- Sinoshenchang Medical
- Suzhou Zhongtian Medical
- Micro-Port Shentong Medical
- Xinkainuo Medical
- Xinwei Medical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Nitinol Thrombectomy Stent Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Nitinol Thrombectomy Stent Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Nitinol Thrombectomy Stent Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Nitinol Thrombectomy Stent Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Nitinol Thrombectomy Stent Market Dynamics
- 2.1 Nitinol Thrombectomy Stent Industry Trends
- 2.2 Nitinol Thrombectomy Stent Industry Drivers
- 2.3 Nitinol Thrombectomy Stent Industry Opportunities and Challenges
- 2.4 Nitinol Thrombectomy Stent Industry Restraints
3 Nitinol Thrombectomy Stent Market by Manufacturers
- 3.1 Global Nitinol Thrombectomy Stent Revenue by Manufacturers (2021-2026)
- 3.2 Global Nitinol Thrombectomy Stent Sales by Manufacturers (2021-2026)
- 3.3 Global Nitinol Thrombectomy Stent Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Nitinol Thrombectomy Stent Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Nitinol Thrombectomy Stent Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Nitinol Thrombectomy Stent Manufacturers, Product Type & Application
- 3.7 Global Nitinol Thrombectomy Stent Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Nitinol Thrombectomy Stent Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Nitinol Thrombectomy Stent Players Market Share by Revenue in 2025
- 3.8.3 2025 Nitinol Thrombectomy Stent Tier 1, Tier 2, and Tier 3
4 Nitinol Thrombectomy Stent Market by Type
- 4.1 Nitinol Thrombectomy Stent Type Introduction
- 4.1.1 Diameter 3MM
- 4.1.2 Diameter 4MM
- 4.1.3 Diameter 6MM
- 4.1.4 Other
- 4.2 Global Nitinol Thrombectomy Stent Sales by Type
- 4.2.1 Global Nitinol Thrombectomy Stent Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Nitinol Thrombectomy Stent Sales by Type (2021-2032)
- 4.2.3 Global Nitinol Thrombectomy Stent Sales Market Share by Type (2021-2032)
- 4.3 Global Nitinol Thrombectomy Stent Revenue by Type
- 4.3.1 Global Nitinol Thrombectomy Stent Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Nitinol Thrombectomy Stent Revenue by Type (2021-2032)
- 4.3.3 Global Nitinol Thrombectomy Stent Revenue Market Share by Type (2021-2032)
5 Nitinol Thrombectomy Stent Market by Application
- 5.1 Nitinol Thrombectomy Stent Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Other
- 5.2 Global Nitinol Thrombectomy Stent Sales by Application
- 5.2.1 Global Nitinol Thrombectomy Stent Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Nitinol Thrombectomy Stent Sales by Application (2021-2032)
- 5.2.3 Global Nitinol Thrombectomy Stent Sales Market Share by Application (2021-2032)
- 5.3 Global Nitinol Thrombectomy Stent Revenue by Application
- 5.3.1 Global Nitinol Thrombectomy Stent Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Nitinol Thrombectomy Stent Revenue by Application (2021-2032)
- 5.3.3 Global Nitinol Thrombectomy Stent Revenue Market Share by Application (2021-2032)
6 Global Nitinol Thrombectomy Stent Sales by Region
- 6.1 Global Nitinol Thrombectomy Stent Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Nitinol Thrombectomy Stent Sales by Region (2021-2032)
- 6.2.1 Global Nitinol Thrombectomy Stent Sales by Region (2021-2026)
- 6.2.2 Global Nitinol Thrombectomy Stent Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Nitinol Thrombectomy Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Nitinol Thrombectomy Stent Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Nitinol Thrombectomy Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Nitinol Thrombectomy Stent Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Nitinol Thrombectomy Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Nitinol Thrombectomy Stent Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Nitinol Thrombectomy Stent Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Nitinol Thrombectomy Stent Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Nitinol Thrombectomy Stent Revenue by Region
- 7.1 Global Nitinol Thrombectomy Stent Revenue by Region
- 7.1.1 Global Nitinol Thrombectomy Stent Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Nitinol Thrombectomy Stent Revenue by Region (2021-2026)
- 7.1.3 Global Nitinol Thrombectomy Stent Revenue by Region (2027-2032)
- 7.1.4 Global Nitinol Thrombectomy Stent Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Nitinol Thrombectomy Stent Revenue (2021-2032)
- 7.2.2 North America Nitinol Thrombectomy Stent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Nitinol Thrombectomy Stent Revenue (2021-2032)
- 7.3.2 Europe Nitinol Thrombectomy Stent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Nitinol Thrombectomy Stent Revenue (2021-2032)
- 7.4.2 Asia-Pacific Nitinol Thrombectomy Stent Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Nitinol Thrombectomy Stent Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Nitinol Thrombectomy Stent Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Acandis GmbH
- 8.1.1 Acandis GmbH Company Information
- 8.1.2 Acandis GmbH Business Overview
- 8.1.3 Acandis GmbH Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Acandis GmbH Nitinol Thrombectomy Stent Product Portfolio
- 8.1.5 Acandis GmbH Recent Developments
- 8.2 Balt Group
- 8.2.1 Balt Group Company Information
- 8.2.2 Balt Group Business Overview
- 8.2.3 Balt Group Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Balt Group Nitinol Thrombectomy Stent Product Portfolio
- 8.2.5 Balt Group Recent Developments
- 8.3 Furukawa Techno Material
- 8.3.1 Furukawa Techno Material Company Information
- 8.3.2 Furukawa Techno Material Business Overview
- 8.3.3 Furukawa Techno Material Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Furukawa Techno Material Nitinol Thrombectomy Stent Product Portfolio
- 8.3.5 Furukawa Techno Material Recent Developments
- 8.4 Johnson & Johnson MedTech
- 8.4.1 Johnson & Johnson MedTech Company Information
- 8.4.2 Johnson & Johnson MedTech Business Overview
- 8.4.3 Johnson & Johnson MedTech Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Johnson & Johnson MedTech Nitinol Thrombectomy Stent Product Portfolio
- 8.4.5 Johnson & Johnson MedTech Recent Developments
- 8.5 Penumbra
- 8.5.1 Penumbra Company Information
- 8.5.2 Penumbra Business Overview
- 8.5.3 Penumbra Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Penumbra Nitinol Thrombectomy Stent Product Portfolio
- 8.5.5 Penumbra Recent Developments
- 8.6 Rapid Medical
- 8.6.1 Rapid Medical Company Information
- 8.6.2 Rapid Medical Business Overview
- 8.6.3 Rapid Medical Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Rapid Medical Nitinol Thrombectomy Stent Product Portfolio
- 8.6.5 Rapid Medical Recent Developments
- 8.7 Stryker
- 8.7.1 Stryker Company Information
- 8.7.2 Stryker Business Overview
- 8.7.3 Stryker Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Stryker Nitinol Thrombectomy Stent Product Portfolio
- 8.7.5 Stryker Recent Developments
- 8.8 Guichuangtongqiao Medical
- 8.8.1 Guichuangtongqiao Medical Company Information
- 8.8.2 Guichuangtongqiao Medical Business Overview
- 8.8.3 Guichuangtongqiao Medical Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Guichuangtongqiao Medical Nitinol Thrombectomy Stent Product Portfolio
- 8.8.5 Guichuangtongqiao Medical Recent Developments
- 8.9 Hemu Biotech
- 8.9.1 Hemu Biotech Company Information
- 8.9.2 Hemu Biotech Business Overview
- 8.9.3 Hemu Biotech Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Hemu Biotech Nitinol Thrombectomy Stent Product Portfolio
- 8.9.5 Hemu Biotech Recent Developments
- 8.10 Jianshi Medical
- 8.10.1 Jianshi Medical Company Information
- 8.10.2 Jianshi Medical Business Overview
- 8.10.3 Jianshi Medical Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Jianshi Medical Nitinol Thrombectomy Stent Product Portfolio
- 8.10.5 Jianshi Medical Recent Developments
- 8.11 Medtronic
- 8.11.1 Medtronic Company Information
- 8.11.2 Medtronic Business Overview
- 8.11.3 Medtronic Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Medtronic Nitinol Thrombectomy Stent Product Portfolio
- 8.11.5 Medtronic Recent Developments
- 8.12 Sinoshenchang Medical
- 8.12.1 Sinoshenchang Medical Company Information
- 8.12.2 Sinoshenchang Medical Business Overview
- 8.12.3 Sinoshenchang Medical Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Sinoshenchang Medical Nitinol Thrombectomy Stent Product Portfolio
- 8.12.5 Sinoshenchang Medical Recent Developments
- 8.13 Suzhou Zhongtian Medical
- 8.13.1 Suzhou Zhongtian Medical Company Information
- 8.13.2 Suzhou Zhongtian Medical Business Overview
- 8.13.3 Suzhou Zhongtian Medical Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Suzhou Zhongtian Medical Nitinol Thrombectomy Stent Product Portfolio
- 8.13.5 Suzhou Zhongtian Medical Recent Developments
- 8.14 Micro-Port Shentong Medical
- 8.14.1 Micro-Port Shentong Medical Company Information
- 8.14.2 Micro-Port Shentong Medical Business Overview
- 8.14.3 Micro-Port Shentong Medical Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Micro-Port Shentong Medical Nitinol Thrombectomy Stent Product Portfolio
- 8.14.5 Micro-Port Shentong Medical Recent Developments
- 8.15 Xinkainuo Medical
- 8.15.1 Xinkainuo Medical Company Information
- 8.15.2 Xinkainuo Medical Business Overview
- 8.15.3 Xinkainuo Medical Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Xinkainuo Medical Nitinol Thrombectomy Stent Product Portfolio
- 8.15.5 Xinkainuo Medical Recent Developments
- 8.16 Xinwei Medical
- 8.16.1 Xinwei Medical Company Information
- 8.16.2 Xinwei Medical Business Overview
- 8.16.3 Xinwei Medical Nitinol Thrombectomy Stent Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Xinwei Medical Nitinol Thrombectomy Stent Product Portfolio
- 8.16.5 Xinwei Medical Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Nitinol Thrombectomy Stent Value Chain Analysis
- 9.1.1 Nitinol Thrombectomy Stent Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Nitinol Thrombectomy Stent Production Mode & Process
- 9.2 Nitinol Thrombectomy Stent Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Nitinol Thrombectomy Stent Distributors
- 9.2.3 Nitinol Thrombectomy Stent Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst